Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers

NCT05233579 is registered in ClinicalTrials.gov with University of California, Davis as lead sponsor.

NCT NCT05233579
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05233579 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Open-Label Trial of Sulforaphane in Premutation Carriers With FXTAS to Find Biomarkers
Lead sponsor
University of California, Davis
Phase
Not applicable
Overall status
Completed
Start date
June 25, 2021
Completion date
January 1, 2023
Enrollment
15 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

fragile x associated tremor/ataxia syndrome (fxtas) (diagnosis)